Navigation Links

Biology News

Synaptics to Present at Pacific Crest Global Technology Leadership Forum

8/3/2015
SAN JOSE, Calif. , Aug. 3, 2015 Synaptics, Inc. (Nasdaq: SYNA ), the leading developer of human interface solutions, today announced that members of the executive management team will present to the investment community at the Pacific Crest Global Technology Leadership Forum on Tuesday, August 11, 2015 at 1:00 p.m. Mountain Time. The conference will be held at the Sonnenalp R... [Comments]

Den 10. internationale konference om Genomics (ICG-10) åbner i oktober

7/31/2015
SHENZHEN , Kina, 31. juli 2015 Den 10. internationale konference om Genomik (ICG-10, www.icg-10.org ) bliver afholdt af BGI fra den 22. - 25. oktober i Shenzhen , Kina. Konferencen fejrer sin 10-års fødselsdag i år. Siden starten i 2006 er ICB blevet en af verdens mest indflydelsesrige årlige møder på 'omik'-feltet, og er en af de mest... [Comments]

La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre

7/31/2015
SHENZHEN, China , 31 de julio de 2015 BGI llevará a cabo la 10ª Conferencia Internacional sobre Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre de 2015, en Shenzhen, China . La conferencia celebra su décimo aniversario este año. Desde su inauguración en 2006, ICG se ha convertido en una de las reuniones anuales más... [Comments]

A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro

7/31/2015
SHENZHEN, China , 31 de julho de 2015 A 10 a. Conferência Internacional sobre Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de 22-25 de outubro de 2015, em Shenzhen, China . A conferência está celebrando seu 10 o. aniversário este ano. Desde sua inauguração em 2006, a ICG se tornou uma das reuniões ma... [Comments]

La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre

7/31/2015
SHENZHEN , Chine, 31 juillet 2015 La 10e Conférence internationale sur la génomique (ICG-10, www.icg-10.org ) sera organisée par le BGI du 22 au 25 octobre 2015 à Shenzhen en Chine. La conférence célèbre son 10e anniversaire cette année. Depuis son inauguration en 2006, l'ICG est devenue l'une des réunions annuelles mondiales... [Comments]

La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre

7/31/2015
SHENZHEN, China , 31 de julio de 2015 La 10 th International Conference on Genomics (ICG-10, www.icg-10.org ) se celebrará por medio de BGI del 22 al 25 de octubre de 2015 en Shenzhen, China . Este año, la conferencia celebra su décimo aniversario. Desde su inauguración en el año 2006, ICG se ha convertido en una de las reuniones anuales m... [Comments]

Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober

7/31/2015
SHENZHEN, China , 31. Juli 2015 Die 10. internationale Konferenz zu Genomik (ICG-10, www.icg-10.org ) wird von BGI veranstaltet und findet vom 22. bis 25. Oktober 2015 in Shenzhen, China , statt. Die Konferenz feiert in diesem Jahr ihr 10. Jubiläum. Seit ihrem Start 2006 ist die ICG weltweit zu einem der einflussreichsten jährlichen Treffen im Bereic... [Comments]

NXT-ID Patents Electronic Crypto-Currency Management Technology

7/31/2015
OXFORD, Conn. , Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), a biometric authentication company focused on the growing mobile commerce market and creator of the Wocket® smart wallet, announces that it has filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND SYSTEM This invention highlights a method to advan... [Comments]

Biology Products

Mouse Anti-Snail, a.a. 150-39 Antibody, Unconjugated from CHEMICON

Description:Snail, a.a. 150-39...
Company:CHEMICON

Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, Unconjugated, Clone LO-MM-3 from Cell Sciences

Description:Anti-Mouse IgM Heavy Chain, Clone LO-MM-3, Monoclonal Antibody...
Company:Cell Sciences

Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc

Description:HOXC11 Antibody...
Company:ProSci, Inc

Rabbit Anti-BAFF-R (CT) BR3 Polyclonal Antibody, Unconjugated from ProSci, Inc

Description:BAFF-R (CT) BR3 Affinity Purified Polyclonal Antibody...
Company:ProSci, Inc

Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc

Description:HOXC11 Antibody...
Company:ProSci, Inc

Biology Technology

White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day

8/4/2015
San Francisco, CA (PRWEB) August 04, 2015 On August 4, 2015, the White House will host a Demo Day with a difference by inviting a diverse selection of entrepreneurs from across the United States to talk about their experiences with innovation and present their big ideas. uBiome co-founder and... [Comments]

FamilyCord Announces Acquisition of LifeLine Cryogenics

8/4/2015
LOS ANGELES , Aug. 4, 2015   California Cryobank Stem Cell Services LLC (dba "FamilyCord") , announced the recent acquisition of LifeLine Cryogenics, an east coast cord blood and reproductive tissue bank primarily servicing the New York tristate area. LifeLine clients will maintain full access to their invaluable tissues, and all prepaid contracts will be honored. Si... [Comments]

Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results

8/4/2015
BEIJING , Aug. 4, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China , today announced that it will release its unaudited financial results for the second quarter, ended June 30, 2015, after market close on Wednesday, August 12, 2015. The Company will host a conference call on Thursday, August 13, 2015, at 8:00 a.m... [Comments]

Halozyme to Host Second Quarter 2015 Financial Results Conference Call

8/3/2015
SAN DIEGO , Aug. 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will webcast its Quarterly Update Conference Call for the second quarter 2015 on Monday, August 10, 2015 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Helen Torley , president and chief executive officer, will lead the call. On the same date post-market, Halozyme will release financial results for the second quart... [Comments]

ArroGen Previews New Fingerprint Molecular Identification Technology

8/3/2015
GREENVILLE, N.C. , Aug. 3, 2015  ArroGen Group, an integrated advanced forensic solutions company, will unveil its new Fingerprint Molecular Identification™ (FMID) technology Aug. 2-8 at the International Association for Identification's educational conference in Sacramento, Calif. FMID, a new category in forensic science, will enable law enforcement agents, di... [Comments]

(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/23/2015)... 2015 Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2015.  ... $4.5 million, a decrease of 33% compared to $6.8 million ... second quarter of 2015 was $0.3 million, or $0.01 per ... diluted share, in the same period a year ago.  ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... The Origin of Species 150 years ago, he deliberately avoided ... the mention of the ,Creator, in the last paragraph of ... to commit on the matter. An international team, led by ... that idea and shows that the British naturalist did explain ...
... 27, 2009 UT Southwestern Medical Center patient Michael LeBlanc, ... newest generation of a mechanical device designed to improve heart ... heart transplant. Called a left-ventricular assist device (LVAD), its ... throughout the body. For Mr. LeBlanc, it will help his ...
... City, Ireland, October 26, 2009 Results of an ... intraocular lens (IOLs) at the time of cataract surgery ... afford protection against the development and/or progression of age-related ... and vision researchers from the Macular Pigment Research Group ...
Cached Biology News:Charles Darwin really did have advanced ideas about the origin of life 2UT Southwestern patient first in North Texas to receive newest-generation heart failure device 2UT Southwestern patient first in North Texas to receive newest-generation heart failure device 3Blue light-filtering increases macular pigment, may protect against age-related vision loss 2Blue light-filtering increases macular pigment, may protect against age-related vision loss 3Blue light-filtering increases macular pigment, may protect against age-related vision loss 4
... screening and binding optimization and built on ... synthesis platform. These microarrays are available as ... Service. Probe Content Our ... 1500 known aptamer sequences. Add up to ...
... LC Sciences provides a comprehensive service ... high density peptide microarrays synthesized on ... using recombinant proteins/antibodies or serum samples. ... your sequence designs, binding assays using ...
... a comprehensive epitope analysis service utilizing ... Paraflo microfluidic chips for immunological studies, ... comprehensive service includes assistance with your ... provided by you, single or dual ...
... aptamer screening and binding optimization and built ... on-chip synthesis platform. Thousands of customer specified ... LC Sciences can provide assistance with custom ... part of our comprehensive DNA/RNA Aptamer Microarray ...
Biology Products:
(Date:8/3/2015)... E-QURE Corp. (OTCQB: EQUR), a ... Signal Therapy device ("BST Device"), a new and novel ... chronic wounds, today announced that the Company has signed ... specializing in medical devices, for the marketing and distribution ... 70 years old, sales, marketing and distribution company in ...
(Date:8/3/2015)... Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: ... on the development of autologous cell therapies, announced today that ... the InvestMNT conference held in Minneapolis, Minnesota ... time. Hall,s presentation will highlight RepliCel,s 18-month milestones including CE ... Europe , clinical data from both RCT-01 (tendon) ...
(Date:7/31/2015)... ... July 31, 2015 , ... Global Resorcinol Market 2015-2019 is ... on the global resorcinol industry. The report highlights the various growth prospects and ... and analysis of primary and secondary inputs from the existing players of the ...
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that it is ... to be held August 5-9 in Marshall. The Ralco Enrichment Center is an interactive ... how agriculture impacts their daily lives. This unique exhibit also features a birthing center ...
Breaking Biology Technology:E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2
... , WALTHAM, Mass., Dec. 15 Repligen Corporation (Nasdaq: ... $731,000 in research funding to support the ongoing development of ... (MDA). This grant will support the completion of preclinical ... for human clinical trials. Support from the MDA not ...
... , , NEW YORK, ... research report is available in its catalogue: , ... Forecasts to 2015, Pipeline Analysis and Reimbursement ... Summary , The author has released its latest ...
... , WILMINGTON, Del. and CHARLOTTESVILLE, Va., Dec. 15 ... of Virginia (UVa) in Charlottesville, today announced that they ... development of new treatments primarily for coronary artery disease ... (PAD). , (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , The ...
Cached Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3